Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Antibe Therapeutics Company Profile (CVE:ATE)

Consensus Ratings for Antibe Therapeutics (CVE:ATE) (?)
Ratings Breakdown: 1 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: C$1.30

Analysts' Ratings History for Antibe Therapeutics (CVE:ATE)
Show:
DateFirmActionRatingPrice TargetDetailsShare
8/20/2014M PartnersInitiated CoverageBuyC$1.30ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 11/24/2012 forward)